AU592072B2 - Novel alkali and alkaline earth metal salts of alpha-(3- pentadecylphenoxy)-isobutyric acids and process for the preparation thereof - Google Patents

Novel alkali and alkaline earth metal salts of alpha-(3- pentadecylphenoxy)-isobutyric acids and process for the preparation thereof Download PDF

Info

Publication number
AU592072B2
AU592072B2 AU52474/86A AU5247486A AU592072B2 AU 592072 B2 AU592072 B2 AU 592072B2 AU 52474/86 A AU52474/86 A AU 52474/86A AU 5247486 A AU5247486 A AU 5247486A AU 592072 B2 AU592072 B2 AU 592072B2
Authority
AU
Australia
Prior art keywords
pentadecylphenoxy
isobutyric acid
preparation
calcium
calcium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU52474/86A
Other languages
English (en)
Other versions
AU5247486A (en
Inventor
Yadavalli Venkata Durga Nageswar
Thallapalli Ramalingam
Maddamsetty Venkateswara Rao
Pralhad Balvantrao Sattur
Gopalakrishna Thygarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU5247486A publication Critical patent/AU5247486A/en
Application granted granted Critical
Publication of AU592072B2 publication Critical patent/AU592072B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AU52474/86A 1983-05-09 1986-01-20 Novel alkali and alkaline earth metal salts of alpha-(3- pentadecylphenoxy)-isobutyric acids and process for the preparation thereof Ceased AU592072B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN292/DEL/83A IN160141B (OSRAM) 1983-05-09 1983-05-09
EP86303552A EP0244526A1 (en) 1983-05-09 1986-05-09 Novel hypolipidemic and hypocholesteremic compounds and their preparation and use

Publications (2)

Publication Number Publication Date
AU5247486A AU5247486A (en) 1987-07-23
AU592072B2 true AU592072B2 (en) 1990-01-04

Family

ID=36889077

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52474/86A Ceased AU592072B2 (en) 1983-05-09 1986-01-20 Novel alkali and alkaline earth metal salts of alpha-(3- pentadecylphenoxy)-isobutyric acids and process for the preparation thereof

Country Status (5)

Country Link
US (1) US4731474A (OSRAM)
EP (1) EP0244526A1 (OSRAM)
JP (1) JPS62185046A (OSRAM)
AU (1) AU592072B2 (OSRAM)
IN (1) IN160141B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544255A (en) * 1994-08-31 1996-08-06 Peripheral Vision Limited Method and system for the capture, storage, transport and authentication of handwritten signatures
US20170121268A1 (en) * 2014-05-23 2017-05-04 Luiz Antonio Soares Romeiro Ppar modulators

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU427159B2 (en) * 1969-08-14 1972-08-15 Parke, Davis & Company 2,2 dimethyl-w-aryloxy alkanoic acids and the salts and esters thereof
AU511212B2 (en) * 1976-10-18 1980-07-31 Paul Kauser-Chepharin, Chemische-Pharmazeutische Industriegesellschaft Process for producing Mg salt ofp-Chlorophenoxyisobutyric acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
IT1141655B (it) * 1980-02-12 1986-10-08 Schiapparelli Spa Nuovi derivati dell'acido propanoico ad attivita' ipolipidemica e ipocolesterolemica

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU427159B2 (en) * 1969-08-14 1972-08-15 Parke, Davis & Company 2,2 dimethyl-w-aryloxy alkanoic acids and the salts and esters thereof
AU511212B2 (en) * 1976-10-18 1980-07-31 Paul Kauser-Chepharin, Chemische-Pharmazeutische Industriegesellschaft Process for producing Mg salt ofp-Chlorophenoxyisobutyric acid

Also Published As

Publication number Publication date
US4731474A (en) 1988-03-15
EP0244526A1 (en) 1987-11-11
IN160141B (OSRAM) 1987-06-27
AU5247486A (en) 1987-07-23
JPS62185046A (ja) 1987-08-13

Similar Documents

Publication Publication Date Title
DE2927715C2 (OSRAM)
US4330559A (en) Method of treating benign prostatic hypertrophy
IE49902B1 (en) 4-substituted-3-hydroxy-3-pyrroline-2,5-dione compounds,process for their preparation and pharmaceutical compositions containing the same
US4732998A (en) Bisphosphonic acids and esters
DE3318989C2 (de) ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
US4110470A (en) Pharmaceutical composition comprising d,l-α-methyl-thyroxine ethyl ester and the salts thereof and the control of cholesterol and triglyceride blood level therewith
DE2317019A1 (de) Neue 4,5-didehydro-prostaglandine
DE2556474C2 (de) Substituierte p-Benzyloxyphenylessigsäuren, ihre Herstellung sowie diese enthaltende Arzneimittel
US4169103A (en) Nonatetraenoic acid derivatives
EP0133935B1 (de) p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln mit hypolipämischer Wirkung
EP0037991B1 (en) 4-alkylsubstituted-3-hydroxy-2-pyrroline-2,5-dione compounds for use in the prevention and treatment of kidney and bladder stones, process for preparing them and pharmaceutical composition containing them
US4176193A (en) Therapeutic isobutyramides
GB1583691A (en) Benzopyrans
KR100224330B1 (ko) 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산
DE3872213T2 (de) 5-substituierte ornithin-derivate.
US4731474A (en) Novel therapeutic compounds useful as hypolipidemic and hypocholesteremic agents
DE1493933A1 (de) Beta-(Naphthyl-1)-isobuttersaeuren und Verfahren zu deren Herstellung
DE2330905A1 (de) Verfahren zur herstellung von neuen 11-deoxyprostaglandinen der e- und freihen
US4163859A (en) Phenoxyldialkyl acetic acids and esters
US4252947A (en) Novel quinazolinone
US3558645A (en) 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
US3153050A (en) Spiro
US4209529A (en) Farnesyl carboxylic acid α-bisabolol ester, a mucosal stabilizing composition and method of manufacturing the same
EP0474358A2 (en) Use of conduritol to inhibit an increase in blood sugar level
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink